Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides
碩士 === 中原大學 === 化學研究所 === 105 === This paper aims to complete neurodegenerative activity of ganglioside Hp-s1 analogues Hp-SJ1、Hp-SJ2、Hp-SJ3 synthesis, we used chemoselective glycosylation reaction and [1+1+2] synthetic strategy. In addition, the synthesis of the sphingosine derivative xyl-13 will b...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/64994835480195387779 |
id |
ndltd-TW-105CYCU5065040 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-105CYCU50650402017-09-22T04:33:53Z http://ndltd.ncl.edu.tw/handle/64994835480195387779 Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides 治療神經退化疾病之藥物的開發研究:神經鞘胺醇的製備與唾液酸醣苷神經鞘醯胺Neu5GcHp-s1及其具多樣性神經鞘醯胺之類似物合成 Jain-Ming Chen 陳建銘 碩士 中原大學 化學研究所 105 This paper aims to complete neurodegenerative activity of ganglioside Hp-s1 analogues Hp-SJ1、Hp-SJ2、Hp-SJ3 synthesis, we used chemoselective glycosylation reaction and [1+1+2] synthetic strategy. In addition, the synthesis of the sphingosine derivative xyl-13 will be carried out to synthesize the ceramide. The synthesis of Hp-SJG1, Hp-SJG2 and Hp-SJG3 main architectures NGLA-1, NGLR-1 and NGLM-1 has been completed. Yow-Fu Tsai 蔡祐輔 2017 學位論文 ; thesis 187 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 中原大學 === 化學研究所 === 105 === This paper aims to complete neurodegenerative activity of ganglioside Hp-s1 analogues Hp-SJ1、Hp-SJ2、Hp-SJ3 synthesis, we used chemoselective glycosylation reaction and [1+1+2] synthetic strategy.
In addition, the synthesis of the sphingosine derivative xyl-13 will be carried out to synthesize the ceramide.
The synthesis of Hp-SJG1, Hp-SJG2 and Hp-SJG3 main architectures NGLA-1, NGLR-1 and NGLM-1 has been completed.
|
author2 |
Yow-Fu Tsai |
author_facet |
Yow-Fu Tsai Jain-Ming Chen 陳建銘 |
author |
Jain-Ming Chen 陳建銘 |
spellingShingle |
Jain-Ming Chen 陳建銘 Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides |
author_sort |
Jain-Ming Chen |
title |
Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides |
title_short |
Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides |
title_full |
Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides |
title_fullStr |
Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides |
title_full_unstemmed |
Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides |
title_sort |
studies on the development of medicines for fighting neurodegenerative diseases: synthesis of sphingosine and ganglioside neu5gchp-s1 and it’s analogues with various ceramides |
publishDate |
2017 |
url |
http://ndltd.ncl.edu.tw/handle/64994835480195387779 |
work_keys_str_mv |
AT jainmingchen studiesonthedevelopmentofmedicinesforfightingneurodegenerativediseasessynthesisofsphingosineandgangliosideneu5gchps1anditsanalogueswithvariousceramides AT chénjiànmíng studiesonthedevelopmentofmedicinesforfightingneurodegenerativediseasessynthesisofsphingosineandgangliosideneu5gchps1anditsanalogueswithvariousceramides AT jainmingchen zhìliáoshénjīngtuìhuàjíbìngzhīyàowùdekāifāyánjiūshénjīngqiàoànchúndezhìbèiyǔtuòyèsuāntánggānshénjīngqiàoxīànneu5gchps1jíqíjùduōyàngxìngshénjīngqiàoxīànzhīlèishìwùhéchéng AT chénjiànmíng zhìliáoshénjīngtuìhuàjíbìngzhīyàowùdekāifāyánjiūshénjīngqiàoànchúndezhìbèiyǔtuòyèsuāntánggānshénjīngqiàoxīànneu5gchps1jíqíjùduōyàngxìngshénjīngqiàoxīànzhīlèishìwùhéchéng |
_version_ |
1718539541644574720 |